Atlas Trials

Peter Brett, MD

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Peter Brett, MD

RecordFirmDate
Open-Label Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally Advanced Oral Cavity Squamous Cell Carcinoma (NCT07733466)Peter Brett, MD2026-08-15

Track Peter Brett, MD automatically

Every clearance here is in the API, with alerts when new ones post.